Effect of CD47 Blockade on Vascular Inflammation

N Engl J Med. 2021 Jan 28;384(4):382-383. doi: 10.1056/NEJMc2029834.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Atherosclerosis / drug therapy
  • CD47 Antigen / antagonists & inhibitors*
  • Carotid Artery Diseases / diagnostic imaging
  • Carotid Artery Diseases / drug therapy*
  • Carotid Artery Diseases / metabolism
  • Female
  • Fluorodeoxyglucose F18 / metabolism
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Inflammation / drug therapy*
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Radiopharmaceuticals / metabolism
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal, Humanized
  • CD47 Antigen
  • CD47 protein, human
  • Immune Checkpoint Inhibitors
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • magrolimab